Answers are grounded in this paper and cite their sources.
Merrilactone A (1) has been shown to possess neurotrophic activity and thus is expected to hold therapeutic potential in the treatment of neurodegeneration diseases. In this paper, we report the total synthesis of (+/-)-1, employing, as key steps, a novel desymmetrization protocol of meso-diketone to construct the core cis-bicyclo[3.3.0]octyl system of 1 (3 --> 2) and a radical cyclization to install the highly congested C9-quaternary carbon (16 --> 17).
No takes yet. Share an insight, caveat, or question.
Inoue et al. (2003) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: